Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab + Methotrexate Dose Response in Early RA
NCT01185301Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2010
- Primary completion
- Sep 2012
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by AbbVie Inc.. Started Oct 2010; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01185301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185301.